Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro

Antivir Chem Chemother. 1998 Nov;9(6):491-6. doi: 10.1177/095632029800900605.

Abstract

Oxysterols, oxygenated derivatives of cholesterol selected for their cytostatic activity and their inhibitory effect on cholesterol synthesis, have been investigated for their anti-human immunodeficiency virus (HIV) activity in vitro. The three oxysterols tested, 7 beta-hydroxycholesterol (7 beta-OHC), 25-hydroxycholesterol (25-OHC) and 7 beta, 25-dihydroxycholesterol (7,25-OHC), inhibit viral replication at micromolar concentrations. The selectivity indexes for 7 beta-OHC and 25-OHC are quite modest (2 to 8) but reproducible; the dihydroxycholesterol 7,25-OHC exhibited antiviral properties at concentrations 13- to 25-fold lower than the highest concentration tested at which no toxicity was measurable. Oxysterols are naturally occurring compounds, and we speculate on their physiological relevance in HIV-infected individuals.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / pharmacology*
  • Cell Line
  • Cholesterol / pharmacology*
  • DNA, Viral / analysis
  • Drug Evaluation, Preclinical
  • HIV-1 / drug effects*
  • HIV-1 / isolation & purification
  • HIV-1 / physiology
  • HIV-2 / drug effects*
  • HIV-2 / isolation & purification
  • HIV-2 / physiology
  • Humans
  • Hydroxycholesterols / pharmacology*
  • Lymphocytes / virology
  • Proviruses / isolation & purification
  • Virus Replication / drug effects*

Substances

  • Anti-HIV Agents
  • DNA, Viral
  • Hydroxycholesterols
  • 7,25-dihydroxycholesterol
  • cholest-5-en-3 beta,7 alpha-diol
  • 25-hydroxycholesterol
  • Cholesterol